Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Investigation, Laboratory test, Physical examination
Clinical narrative: patients were administered expired doses of the Moderna COVID-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients were administered expired doses of the Moderna COVID-19 vaccine) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 003B21A and 003B21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: VACCINE. INFLUENZA (Series 1) on 09-Oct-2019, VACCINE, INFLUENZA (Series 2) on 15-Oct-2020 and VACCINE. INFLUENZA (Series 3) on 21-Sep-2021. Past adverse reactions to the above products included No adverse effect with VACCINE, INFLUENZA, VACCINE. INFLUENZA and VACCINE. INFLUENZA. Family history included Heart disease, unspecified since an unknown date and Diabetes since an unknown date. Concurrent medical conditions included Arthralgia (bilateral hands), Obstructive sleep apnoea syndrome, Renal insufficiency, Infectious colitis (infectioius), Diarrhea, Impaired fasting glucose, Chest discomfort, Vitamin B12 deficiency, Pain in joint involving lower leg, Eustachian tube dysfunction, Hypertension, Herpes zoster, Iliofemoral (ligament) sprain, Abdominal pain, Hyperlipidemia and Coronary artery disease (nonobstructive calcium heart score of 28). Concomitant products included NEBIVOLOL HCL, ACETYLSALICYLIC ACID (ASPIRIN 81), AMLODIPINE BESYLATE, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), COENZYME Q10 [UBIDECARENONE] and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients were administered expired doses of the Moderna COVID-19 vaccine). On 10-Nov-2021, EXPIRED PRODUCT ADMINISTERED (patients were administered expired doses of the Moderna COVID-19 vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Investigation: results not reported Screen Lung cancer, Results not provided, results not reported Screen Skin cancer, Results not provided, results not reported Screening for Prostrate cancer, Results not provided and results not reported Screen Colon cancer, Results not provided. On an unknown date, Laboratory test: results not reported Results not provided. On an unknown date, Physical examination: results not reported Physical exam routine, Results not provided.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The dose was administered after 30-day Use by Date or after manufacturer date of expiry.  It was reported that the patient had observation and evaluation for suspected exposure to other biological agent. The patient had H1N1 vaccine and was an antihyperlipidemic user. The patient also had ear symptoms.  The patient underwent Lab exam, screen lung cancer, screen skin cancer, screening for prostate cancer and screen colon cancer. The patient had few pending services such as HEMOCCULT or SIGMOID and TD booster.  No treatment information was provided.